drugset / Trial / NCT00812487
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Phase 1/2
Completed
75 enrolled
Kathleen Dungan
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
High glucose as well as fluctuations (rapid swings) in blood glucose can contribute to severe hospital complications and even death.
Timeline
- Start
- 2009-01
- Primary completion
- 2012-08
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulin | Protein / enzyme biologic | — | Intravenous |